This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Novartis Ag. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Herbert Jaksche: Innovator in Therapeutic Agents
Introduction
Herbert Jaksche is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic agents. With a total of 2 patents, his work focuses on innovative compounds that serve as inhibitors for specific biological activities.
Latest Patents
Herbert Jaksche's latest patents include "N-arylsulfonyl-2,3-dihydro-1H-indoles and the use thereof as CCR9 inhibitors" and "N-(benzenesulphonyl)-2,3-dihydro-1H-indols, wherein the indol is substituted by cyano, carboxy or alkylcarbonyloxy and their use as therapeutical agents." These patents detail compounds that inhibit CCR9 activity, showcasing their potential for therapeutic treatment. The compounds described in his patents are characterized by specific structural features that enhance their efficacy as therapeutic agents.
Career Highlights
Herbert Jaksche is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on the development of innovative therapeutic solutions. His contributions have been instrumental in advancing the understanding and treatment of various medical conditions.
Collaborations
Throughout his career, Herbert has collaborated with esteemed colleagues such as Jose M Carballido Herrera and Gudrun Werner. These collaborations have fostered a productive environment for innovation and research in the field of medicinal chemistry.
Conclusion
Herbert Jaksche's work exemplifies the impact of innovation in the development of therapeutic agents. His patents and collaborations highlight his commitment to advancing medical science. His contributions continue to influence the field and pave the way for future discoveries.